Xiangyu Medical Co

Xiangyu Medical Co Current Liabilities

The Current Liabilities of Xiangyu Medical Co (688626.SS) as of Nov 4, 2026 is 146.78 M CNY. In the previous year, Current Liabilities was 771.14 M CNY — a change of -80.97% (lower).

Current Liabilities

146.78 MCNY

YoY

-80.97%

Last updated:

Current Liabilities of Xiangyu Medical Co is 2025 146.78 M CNY. Current Liabilities of Xiangyu Medical Co was 2024 771.14 M CNY. It decreases by -80.97% lower compared to the previous year.

The Xiangyu Medical Co Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
129.08 M CNY
Jan 1, 2019
149.21 M CNY
Jan 1, 2020
160.66 M CNY
Jan 1, 2021
191.50 M CNY
Jan 1, 2022
376.48 M CNY
Jan 1, 2023
399.29 M CNY
Jan 1, 2024
771.14 M CNY
Jan 1, 2025
146.78 M CNY
The Xiangyu Medical Co Current Liabilities history
YEARCurrent LiabilitiesYoY
146.78 MCNY-80.97%
771.14 MCNY+93.13%
399.29 MCNY+6.06%
376.48 MCNY+96.60%
191.50 MCNY+19.20%
160.66 MCNY+7.68%
149.21 MCNY+15.60%
129.08 MCNY+226.23%
39.57 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Xiangyu Medical Co Stock analysis

What does Xiangyu Medical Co do? Xiangyu Medical Co., Ltd. develops, produces, and sells rehabilitation medical equipment, focusing on intelligent rehabilitation solutions for pain, neurology, orthopedics, traditional Chinese medicine, postpartum, postoperative, and cardiopulmonary fields. The company offers three main product categories: rehabilitation assessment, rehabilitation training, and rehabilitation physiotherapy. It primarily serves the domestic market within China, leveraging its independent research and development capabilities to address diverse rehabilitation needs across multiple medical specialties. The firm's revenue is generated through the sale of its intelligent rehabilitation equipment, with products targeting healthcare facilities, hospitals, and rehabilitation centers. These institutions purchase the equipment to support patient recovery in specialized areas such as neurology, orthopedics, and postpartum care. Xiangyu Medical's domestic market focus ensures consistent demand for its tailored rehabilitation solutions. Xiangyu Medical's business model centers on in-house research and development, enabling the creation of specialized equipment that meets the specific requirements of rehabilitation fields. By concentrating on domestic sales, the company avoids complex international distribution challenges while maintaining a strong presence in China's growing healthcare sector. The company's product portfolio aligns with the expanding demand for integrated medical care solutions within China's healthcare system. Xiangyu Medical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Xiangyu Medical Co stock

Current Liabilities of Xiangyu Medical Co is 146.78 M CNY in 2025.

Current Liabilities of Xiangyu Medical Co changed from 771.14 M CNY to 146.78 M CNY, representing a -80.97% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Xiangyu Medical Co since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Xiangyu Medical Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Xiangyu Medical Co

All Key Metrics — Xiangyu Medical Co